SOFI - Hot Stocks: Another oil rally; RENN rises on settlement; CCXI approval; ALLO clinical hold; NKTX delayed data

While stocks finished fractionally lower on Friday after a disappointing payroll report, oil prices continued their steady climb, driving to a multi-year high. This powered stocks in the sector, with APA Corp. (NASDAQ:APA), Pioneer Natural Resources (NYSE:PXD), Hess Corp. (NYSE:HES) and EOG Resources (NYSE:EOG) all posting notable gains. Outside the energy space, Renren (NYSE:RENN) was another noteworthy winner on the session. Shares jumped nearly 50% on news of a $300M settlement in a shareholder lawsuit brought against the company's founders. ChemoCentryx (NASDAQ:CCXI) also drew massive buying interest. Shares nearly doubled after the U.S. Food and Drug Administration approved its TAVNEOS drug. FDA news had the opposite impact on Allogene (NASDAQ:ALLO). The stock plunged after the regulatory agency placed a clinical hold on studies of its AlloCAR T. Elsewhere in the drug development realm, Nkarta (NASDAQ:NKTX) also fell sharply after it was forced to delay the results of an ongoing clinical

For further details see:

Hot Stocks: Another oil rally; RENN rises on settlement; CCXI approval; ALLO clinical hold; NKTX delayed data